Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Insulin Pumps and Continuous Glucose Monitors Market Report Overview
The insulin pumps and continuous glucose monitors market size was $10.57 billion in 2022. An insulin pump administers programmed doses of insulin for diabetes management and a continuous glucose monitoring system helps in the continuous measurement of blood glucose.
Insulin Pumps and Continuous Glucose Monitors Market Outlook, 2022-2033 ($ Billion)
Buy Full Report for More Insights into the Insulin Pumps and Continuous Glucose Monitors Market Forecast
The Insulin Pumps and Continuous Glucose Monitors market research report is built to visualize quantitative market trends within the Diabetes Care Devices therapeutic area. The model discusses in detail the impact of COVID-19 on the Insulin Pumps and Continuous Glucose Monitors market for the year 2020 and beyond. Each of the covered 39 countries’ color-coded and fully sourced market models are equipped with epidemiology-based indications with procedure volumes.
Market Size (2022) | $10.57 billion |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · Insulin Pumps
· Blood Glucose Meters |
Key Regions | · North America
· Europe · Asia Pacific · South America · Middle East and Africa |
Leading Companies | · Medtronic Plc
· Abbott Laboratories · DexCom Inc · Senseonics Inc · Insulet Corp · F. Hoffmann-La Roche Ltd · Ypsomed Holding AG · Tandem Diabetes Care Inc · MannKind Corp |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Insulin Pumps and Continuous Glucose Monitors Market Dynamics
The Diabetes Care Devices (DCD) market has witnessed massive demand over the past few years due to the increase in the prevalence number of people suffering from diabetes and a growing awareness among consumers regarding the availability of new technological advancements in the market. The major growth driver of the DCD market is the increase in incidence and prevalence of diabetes which is the result of a sedentary lifestyle, obesity, and imbalanced diet. The availability of reimbursement policies in developed countries also adds to the growing DCD market. Additionally, harmful effects associated with some of the diabetes care devices and the high cost of the devices hamper the market growth.
Insulin Pumps and Continuous Glucose Monitors Market Segments
The market can be segmented into insulin pumps and blood glucose meters. Insulin pumps led the market in 2022. They can be further segmented into traditional insulin pumps & accessories and patch pumps. Blood glucose meters can be sub-segmented into continuous glucose monitors and continuous glucose monitors – sensors.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Segments, 2022 (%)
Buy Full Report for More Segment Insights into the Insulin Pumps and Continuous Glucose Monitors Market
Insulin Pumps and Continuous Glucose Monitors Market Segmentation by Regions
The key regions in the insulin pumps and continuous glucose monitors market are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America dominated the market in 2022. The US holds a dominating position in this regional market following Canada and Mexico. The market is majorly driven by the increasing prevalence rate of diabetes, increase in the prevalence of obesity, sedentary lifestyle, increasing awareness among consumers, and rapid innovation and advancements in technologies.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Regions, 2022 (%)
Buy Full Report to Know More about the Regions in Insulin Pumps and Continuous Glucose Monitors Market
Insulin Pumps and Continuous Glucose Monitors Market - Competitive Landscape
Some of the leading companies in the insulin pumps and continuous glucose monitors market are Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and MannKind Corp. Medtronic Plc held the largest share of the insulin pumps and continuous glucose monitors market in 2022.
Insulin Pumps and Continuous Glucose Monitors Market Analysis by Companies, 2022 (%)
Buy Full Report to Know More about the Companies in the Insulin Pumps and Continuous Glucose Monitors Market
Segments Covered in the Report
Insulin Pumps and Continuous Glucose Monitors Segments Outlook (Value, $ Billion, 2015-2033)
- Insulin Pumps
- Traditional Insulin Pumps & Accessories
- Traditional Insulin Pump Accessories
- Traditional Insulin Pumps
- Patch Pumps
- Non-Programmable Insulin Patch Pumps
- Programmable Insulin Patch Pumps – Pods
- Programmable Insulin Patch Pumps
- Blood Glucose Meters
- Continuous Glucose Monitors
- Continuous Glucose Monitors – Sensors
- Traditional Insulin Pumps & Accessories
Insulin Pumps and Continuous Glucose Monitors Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
Key Inclusions
Key Inclusions of the market model are:
Currently marketed Insulin Pumps and Continuous Glucose Monitors and evolving competitive landscape –
– Insightful review of the key industry trends.
– Annualized total Insulin Pumps and Continuous Glucose Monitors market revenue by segment and market outlooks from 2015-2033.
– Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
– Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
– SWOT analysis for the Insulin Pumps and Continuous Glucose Monitors market.
– Competitive dynamics insights and trends provided for the Insulin Pumps and Continuous Glucose Monitors market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the market access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country-specific overview of the healthcare system.
– Country-specific reimbursement policies.
– Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered – Medtronic Plc, DexCom Inc, Abbott Laboratories, Senseonics Inc, Ypsomed Holding AG, Tandem Diabetes Care Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, MannKind Corp, and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have a deep understanding of the Insulin Pumps and Continuous Glucose Monitors marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on the insulin pumps and continuous glucose monitors market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the insulin pumps and continuous glucose monitors market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the insulin pumps and continuous glucose monitors market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific insulin pumps and continuous glucose monitors market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
DexCom Inc
Senseonics Inc
Insulet Corp
F. Hoffmann-La Roche Ltd
Ypsomed Holding AG
Tandem Diabetes Care Inc
MannKind Corp
Others
Frequently asked questions
-
What was the insulin pumps and continuous glucose monitors market size in 2022?
The insulin pumps and continuous glucose monitors market size was $10.57 billion in 2022.
-
Which region held the largest share of the insulin pumps and continuous glucose monitors market?
North America held the largest insulin pumps and continuous glucose monitors market share in 2022.
-
Which segment held the largest share of the insulin pumps and continuous glucose monitors market?
Insulin pumps led the insulin pumps and continuous glucose monitors market in 2022.
-
Who are the major players operating in the insulin pumps and continuous glucose monitors market?
Some of the leading companies in the insulin pumps and continuous glucose monitors market are Medtronic Plc, Abbott Laboratories, DexCom Inc, Senseonics Inc, Insulet Corp, F. Hoffmann-La Roche Ltd, Ypsomed Holding AG, Tandem Diabetes Care Inc, and MannKind Corp.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.